Jonathan Moss
16Patents
6h-index
10Co-inventors
63Inventor score
Filing activity: Nov 3, 1997 → Nov 16, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5972954A | Use of methylnaltrexone and related compounds | Human Necessities | 151 | Expired |
| US6274591A | Use of methylnaltrexone and related compounds | Human Necessities | 70 | Expired |
| US6608075B2 | Use of methylnaltrexone and related compounds | Human Necessities | 61 | Expired |
| US6559158B1 | Use of methylnaltrexone and related compounds to treat chronic opioid use side affects | Human Necessities | 45 | Expired |
| US9526723B2 | Treatment with opioid antagonists and mTOR inhibitors | Human Necessities | 7 | Active |
| US8518962B2 | Use of opioid antagonists | Physics | 6 | Active |
| US7372891B1 | Signal generator and decoder | Electricity | 3 | Expired |
| US8685995B2 | Treatment with opioid antagonists and mTOR inhibitors | Human Necessities | 2 | Active |
| US6126612A | Method for detecting cyanide in cutaneously transpired gas | Physics | 1 | Expired |
| US8524731B2 | Use of opioid antagonists to attenuate endothelial cell proliferation and migration | Human Necessities | 1 | Active |
| US9675602B2 | Use of opioid antagonists to attenuate endothelial cell proliferation and migration | Human Necessities | 0 | Active |
| US9717725B2 | Use of opioid antagonists | Physics | 0 | Active |
| US9662390B2 | Use of opioid antagonists to attenuate endothelial cell proliferation and migration | Human Necessities | 0 | Expired |
| US9662325B2 | Use of opioid antagonists to attenuate endothelial cell proliferation and migration | Human Necessities | 0 | Active |
| US10383869B2 | Treatment with opioid antagonists and mTOR inhibitors | Human Necessities | 0 | Active |
| US6399036B1 | Use of solid hydroxides as scavenging materials for cyanide gas | Performing Operations; Transporting | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.